Global Recombinant protein market is estimated to reach $ 613.6 million by 2026; growing at a CAGR of 6.6% till 2026

Global Recombinant Protein Market Research Report, Growth Trends and Competitive Analysis 2021-2027

Recombinant proteins are designed by transfecting foreign genes into a host cell. It is used to produce pharmaceutical products, antibodies and enzymes for disease treatment, protein-based polymers for drug delivery, protein scaffolds for tissue engineering, and for a myriad of other uses.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

Get sample copy of this report @
https://www.infinitybusinessinsights.com/request_sample.php?id=614370

Top key players @ AMSBIO, Abcam plc, Bio-Rad Laboratories, Inc., Merck Millipore Limited, Thermo Fisher Scientific, Inc., BPS Bioscience Inc., PerkinElmer, Inc, GenScript Corporation, Crown Bioscience, Inc., and Sanofi SA.

Technological advancement in recombinant protein production is driving the market. For instance, Lonza has expanded its cell culture media portfolio with the GSv9 Media and Feeds, providing a fully integrated solution designed to optimize recombinant protein production using Lonza’s GS Gene Expression System. The new animal-component free media and feeds are intended to be easy to implement, highly robust and enable greater batch-to-batch consistency. The biopharmaceutical manufacturers develop streamlined and scalable bioproduction processes. Additionally, iBio, Inc. has introduced the FastGlycaneering Development Service, which includes a new glycosylation technology for engineering high-performance recombinant proteins. The Biopharmaceutical and biosimilar producers can take advantage of low-cost afucosylation controls, oligomannose modification capabilities, and more custom glycosylation techniques using iBio’s plant-based manufacturing platform to rapidly develop high-quality biobetters, novel antibody therapeutics, and biosimilars.

Hormones, Plasma Protein Factor, Immune Checkpoint Regulators, Recombinant Metabolic Enzymes, Growth Factors, Cytokines, and Others is the product type segment of the market scope. By application the market is divided into Biopharmaceutical Production, Basic Research, Drug Discovery & Development, and Others. By end user the market is further divided into Academic & Research Institutes, Biopharmaceutical Companies, Contract Research Organizations, and Others. The report covers value of the global market by product type, application, and end user.

Based on the product type, Immune Checkpoint Regulators has shown significant growth in 2019, owing to the commercialization of recombinant protein products, increasing clinical studies for recombinant protein products and strategic partnership between companies to commercialize recombinant protein.

If you have any special requirements, please let us know and we will offer you the report as you want.
North America, Europe, Asia Pacific, South America, and Middle East & Africa are taken into consideration at the global recombinant protein value figures. While North America is further categorized into enhancing the United States, Canada, and Mexico, Europe is split into the United Kingdom, Germany, France, Italy, and Rest of Europe. Asia-Pacific covers India, China, Japan, South Korea, and Rest of Asia Pacific in its scope. South America is bifurcated into Brazil, Argentina, and Rest of South America, with Middle East & Africa involving GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.

North America was dominating the recombinant protein market in 2019, due to the technological advancement in recombinant protein production, rising investment for the development of recombinant protein product, and strategic partnership between companies to develop recombinant protein.

About Us:
Infinity Business Insights is a market research company that offers market and business research intelligence all around the world. We are specialized in offering the services in various industry verticals to recognize their highest-value chance, address their most analytical challenges, and alter their work.
We attain particular and niche demand of the industry while stabilize the quantum of standard with specified time and trace crucial movement at both the domestic and universal levels. The particular products and services provided by Infinity Business Insights cover vital technological, scientific and economic developments in industrial, pharmaceutical and high technology companies.

Contact Us:
Amit J
Sales Coordinator
+1-518-300-3575
amit@infinitybusinessinsights.com
https://mobile.twitter.com/IBInsightsLLP
https://facebook.com/Infinity-Business-Insights-352172809160429
https://www.linkedin.com/company/infinity-business-insights/

This release was published on openPR.